Abstract
The specific features of cryochemical technology for producton of new nanosized modifications of drug substances are observed. The method is based on transformation of the initial substance in gas phase and followed by the organization of molecular flow to the cooled surfaces. The results of study of physicochemical properties of nanosized drug substances obtained for different applications are presented: cardiological carvedilol, cytostatic imatinibe mesilate, steroid hormone Δ5 androstendiol-3β,17β, psychoactive phenasepam. On example of the last compound the results of biological tests are presented.
Similar content being viewed by others
References
Nanoscale Materials in Chemistry, 2 ed., Klabunde K.J. and Richards, R.M., Eds., Hoboken (New Jersey): Wiley, 2009, 660-dc22 2008053437 US.
Sergeev, G.B. and Klabunde, K.J., in Nanochemistry, 2 ed., Amsterdam: Elsevier, 2013.
Bochenkov, V.E. and Sergeev, G.B., Russ. Chem. Rev., 2007, vol. 76, no. 11, p. 1084.
Ruoslahti, E., Bhatia, S.N., and Sailor, M.J., J. Cell Biol., 2010, vol. 188, no. 6, pp. 759–768.
Utekhina, A.Yu. and Sergeev, G.B., Russ. Chem. Rev., 2011, vol. 80, no. 3, pp. 219.
Polymorphism: in the Pharmaceutical Industry, Hilfiker, R., Ed., Weinheim: Wiley, 2006.
RF Patent 2295511.
Morozov, Yu.N., Mikhalev, S.P., Shabatin, V.P., Kolotilov, P.N., and Sergeev, G.B., Vestn. Mosk. Gos. Univ., Ser. 2: Khim., vol. 51, no. 4, pp. 288–295.
Knudsen, M., Ann. Phys., 1909, no. 29, p. 179
Portnov, V.M. and Chuprunov, E.V., Vozniknovenie i rost krystallov (Crystal Formation and Growth), Moscow, Phyzmatlit, 2006
RF Patent 2366653.
Sergeev, B.M., Mikhalev, S.P., Morozov, Yu.N., Shabatin, V.P., Kolotilov, P.N., and Sergeev, G.B., Vestn. Mosk. Gos. Univ., Ser. 2: Khim., vol. 51, no. 6, pp. 440–444.
RF Patent 2365587.
WO Patent 2004/106326 A1.
Whitnall, M.H., Villa, V., Seed, T.M., and Benjack, J., Immunopharmacol. Immunotoxicol., 2005, vol. 27, pp. 15–32.
Utekhina, A.Yu., Moskova, A.A., Morozov, Yu.N., Kolotilov, P.N., Sergeev, B.M., and Sergeev, G.B., Butlerov. Soobshch., 2011, vol. 25, no. 6, pp. 71–76.
RF Patent 2430094.
RF Patent 2440120.
Sergeev, G.B., Sergeev B.M., Morozov, Yu.N., and Chernyshev, V.V., Acta Crystallogr.: Sect. E., 2010, vol. 66, p. o2623.
Karapetyan, A.A., Andrianov, V.G., Struchkov, Yu.T., Bogatskii, A.V., Andronati, S.A., and Korotenko, T.I., Bioorg. Khim., 1979, vol. 5, no. 11, pp. 1684–1690.
Lipinski, C., Am. Pharm. Rev., 2002, vol. 5, pp. 82–85.
Keck, C.M. and Müller, R., Eur. J. Pharm. Biopharm., 2013, vol. 84, no. 3, pp. 445–448. doi: http://dx.doi.org/10.1016/j.ejpb.2013.01.001.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © Yu.N. Morozov, A.Yu. Utekhina, V.P. Shabatin, V.V. Chernyshev, G.B. Sergeev, 2012, published in Rossiiskii Khimicheskii Zhurnal, 2012, Vol. 56, Nos. 5–6, pp. 43–51.
Rights and permissions
About this article
Cite this article
Morozov, Y.N., Utekhina, A.Y., Shabatin, V.P. et al. Cryosynthesis of nanosized drug substances. Russ J Gen Chem 84, 1010–1017 (2014). https://doi.org/10.1134/S1070363214050387
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363214050387